1/1
2 files

Supplementary Materials. Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.

dataset
posted on 22.03.2022, 10:31 authored by Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E. Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Müller, Michael Böhm

Supplemental Table 1: Comparison of HCRU between SPC and MPC cohorts (absolute numbers; based on matched cohorts).

Supplemental Table 2: Comparison of direct CV-related costs between SPC and MPC cohorts (absolute numbers; based on matched cohorts).

Funding

Funding provided by APONTIS PHARMA Deutschland GmbH & Co. KG, Monheim, Germany.

History